-
1
-
-
34548802579
-
Rheumatoid lung disease
-
Brown KK. Rheumatoid lung disease. Proc Am Thorac Soc, 2007, 15: 443-448.
-
(2007)
Proc Am Thorac Soc
, vol.15
, pp. 443-448
-
-
Brown, K.K.1
-
4
-
-
34547455366
-
Rheumatoid arthritis treatment and the risk of severe interstitial lung disease
-
DOI 10.1080/03009740601153774, PII 780897116, Extending the Bounds of Power Transition Theory
-
Wolfe F, Caplan L, Michaud K. Rheumatoid arthritis treatment and the risk of severe interstitial lung disease. Scand J Rheumatol, 2007, 36: 172-178. (Pubitemid 47174545)
-
(2007)
Scandinavian Journal of Rheumatology
, vol.36
, Issue.3
, pp. 172-178
-
-
Wolfe, F.1
Caplan, L.2
Michaud, K.3
-
5
-
-
33750188827
-
Prevalence of interstitial lung involvement in patients with connective tissue diseases assessed with high-resolution computed tomography
-
Afeltra A, Zennaro D, Garzia P, et al. Prevalence of interstitial lung involvement in patients with connective tissue diseases assessed with high-resolution computed tomography. Scand J Rheumatol, 2006, 35: 388-394.
-
(2006)
Scand J Rheumatol
, vol.35
, pp. 388-394
-
-
Afeltra, A.1
Zennaro, D.2
Garzia, P.3
-
6
-
-
34548548440
-
Therapeutic effects of alpha-lipoic acid on bleomycin-induced pulmonary fibrosis in rats
-
Liu R, Ahmed KM, Nantajit D, et al. Therapeutic effects of alpha-lipoic acid on bleomycin-induced pulmonary fibrosis in rats. Int J Mol Med, 2007, 19: 865-873.
-
(2007)
Int J Mol Med
, vol.19
, pp. 865-873
-
-
Liu, R.1
Ahmed, K.M.2
Nantajit, D.3
-
7
-
-
33644861102
-
Pulmonary involvement in lifelong non-smoking patients with rheumatoid arthritis and ankylosing spondylitis without respiratory symptoms
-
Ayhan-Ardic FF, Oken O, Yorgancioglu ZR, et al. Pulmonary involvement in lifelong non-smoking patients with rheumatoid arthritis and ankylosing spondylitis without respiratory symptoms. Clin Rheumatol, 2006, 25: 213-218.
-
(2006)
Clin Rheumatol
, vol.25
, pp. 213-218
-
-
Ayhan-Ardic, F.F.1
Oken, O.2
Yorgancioglu, Z.R.3
-
8
-
-
24644463783
-
Comparison of disease progression and mortality of connective tissue disease-related interstitial lung disease and idiopathic interstitial pneumonia
-
Kocheril SV, Appleton BE, Somers EC, et al. Comparison of disease progression and mortality of connective tissue disease-related interstitial lung disease and idiopathic interstitial pneumonia. Arthritis Rheum, 2005, 53: 549-557.
-
(2005)
Arthritis Rheum
, vol.53
, pp. 549-557
-
-
Kocheril, S.V.1
Appleton, B.E.2
Somers, E.C.3
-
9
-
-
0842280636
-
-
Biederer J, Schnabel A, Muhle C, et al. Correlation between HRCT findings, pulmonary function tests and bronchoalveolar lavage cytology in interstitial lung disease associated with rheumatoid arthritis, 2004, 14: 272-280.
-
(2004)
Correlation between HRCT Findings, Pulmonary Function Tests and Bronchoalveolar Lavage Cytology in Interstitial Lung Disease Associated with Rheumatoid Arthritis
, vol.14
, pp. 272-280
-
-
Biederer, J.1
Schnabel, A.2
Muhle, C.3
-
10
-
-
33646479007
-
Leflunomide use and the risk of interstitial lung disease in rheumatoid arthritis
-
Suissa S, Hudson M, Ernst P. Leflunomide use and the risk of interstitial lung disease in rheumatoid arthritis. Arthritis Rheum, 2006, 54: 1435-1439.
-
(2006)
Arthritis Rheum
, vol.54
, pp. 1435-1439
-
-
Suissa, S.1
Hudson, M.2
Ernst, P.3
-
11
-
-
3242677781
-
Newer disease-modifying antirheumatic drugs and the risk of serious hepatic adverse events in patients with rheumatoid arthritis
-
Suissa S, Ernst P, Hudson M, et al. Newer disease-modifying antirheumatic drugs and the risk of serious hepatic adverse events in patients with rheumatoid arthritis. Am J Med, 2004, 117: 8792.
-
(2004)
Am J Med
, vol.117
, pp. 8792
-
-
Suissa, S.1
Ernst, P.2
Hudson, M.3
-
12
-
-
24644463783
-
Comparison of disease progression and mortality of connective tissue disease-related interstitial lung disease and idiopathic interstitial pneumonia
-
Kocheril SV, Appleton BE, Somers EC, et al. Comparison of disease progression and mortality of connective tissue disease-related interstitial lung disease and idiopathic interstitial pneumonia. Arthritis Rheum, 2005, 53: 549-557.
-
(2005)
Arthritis Rheum
, vol.53
, pp. 549-557
-
-
Kocheril, S.V.1
Appleton, B.E.2
Somers, E.C.3
-
13
-
-
33750709280
-
Expression of insulin-like growth factor-I(IGF-I) in alveolar macrophages and lymphocytes obtained by bronchoalveolar lavage (BAL) in interstitial lung diseases (ILD). Assessment of IGF-I as a potential local mitogen and antiapoptotic cytokine
-
Kopiński P, Sladek K, Szczeklik J, et al. Expression of insulin-like growth factor-I(IGF-I) in alveolar macrophages and lymphocytes obtained by bronchoalveolar lavage (BAL) in interstitial lung diseases (ILD). Assessment of IGF-I as a potential local mitogen and antiapoptotic cytokine. Folia Histochem Cytobiol, 2006, 44: 249-258.
-
(2006)
Folia Histochem Cytobiol
, vol.44
, pp. 249-258
-
-
Kopiński, P.1
Sladek, K.2
Szczeklik, J.3
|